Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
NATO Adds Tanium to Its Information Assurance Product Catalogue (NIAPC)
-
GUTHRIE NAMES DAVID FLETCHER VICE PRESIDENT OF THE PULSE CENTER
-
BioMedNewsBreaks — SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation
-
This Small Business Month, KeyBank Highlights Advice Driven Business Banking Through Certified Cash Flow Advisor Program
-
Saviynt Strengthens Executive Team to Accelerate AI Identity Security Leadership
-
99% of High Point University Graduates Continue to Be Employed or Furthering Their Education Within 180 Days of Graduation
-
CMB Regional Centers Introduces Atlanta Logistics EB-5 Offering
-
Becker’s Names Leap Distributors CEO Allen Mason to 2026 Great Leaders in Healthcare List
-
Vice Holdings LLC Expands Luxury Residential Development Portfolio Across Metro Atlanta
-
AccountTECH Makes a Bold Bet on Private AI
-
Metallium Successfully Completes First 12-Hour Continuous Single Flash Joule Heating Reactor Run
-
WallachBeth Capital Announces SU Group Pricing of $6 Million Public Offering
-
Breakthrough T1D Southern Ohio Chapter Hosts 42nd Annual Cincinnatian of the Year Gala, Raising Over $1 Million
-
Veeam Launches DataAI™ Command Platform, the Industry's First Unified Data and AI Trust Infrastructure for the Agentic Era
-
North Media Q1 2026: The Group improved its operating profit and financial guidance narrowed
-
VegaShares Announces Launch of Autocallable Income ETF (VAIE)
-
Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress
-
NEW REPORT: YOUTH JOBLESSNESS' SILENT EMERGENCY FOR NEARLY 80 YEARS
-
Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress
-
AppSwarm Launches BARAI, Its AI-Powered App, on the Google Play Store
-
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Q1 2026 Results, Highlights TONMYA Commercial Growth and Pipeline Progress
-
Mobix Labs Expands Boeing 737NG Aerospace Deployment
-
CEO.CA's Inside the Boardroom: Thistle Resources Goes Public with Gold and Antimony Focus in Bathurst Mining Camp
-
Vereigen Media Announces 'London Marketers Connect' An Exclusive B2B Marketing Gathering on the Thames, June 2026
-
"Who is Moab", A People-First Approach to Destination Storytelling, Debuts by the Moab Office of Tourism and reelCreative
-
Cathetrix and TubeX to Showcase Advanced Catheter Securement Solutions at WHX 2026
-
The Nature's Bounty® Brand Introduces New Age-Defying Skin Renewal Supplement for Daily Skin Care
-
HSS Research Supports Routine Imaging Before and After ACL Surgery in Growing Children
-
ManageEngine Announces Native SOAR To Close the Detection-to-Response Gap With Cross-Domain Automation
-
53% of Americans carry credit card balances to cover essential living expenses, Achieve survey finds
-
KatRisk Introduces KatRisk Intelligence and KatRisk Technology, Defining the Future of Catastrophe Risk Decision-Making
-
Airia Named Top Platform in Legal AI at Theorem's Spring 2026 LegalTech Awards
-
Form 8.3 -DCC plc
-
Ciscom Significantly Improved Profits in Q1 2026
-
Airia Named Top Platform in Legal AI at Theorem's Spring 2026 LegalTech Awards
-
Skyward Specialty Appoints Melissa Goto to Lead E&S Brokerage and Inland Marine Businesses
-
Skyward Specialty Appoints Melissa Goto to Lead E&S Brokerage and Inland Marine Businesses
-
Pearl Diver Capital Introduces Investment Grade CLO Strategy Following Strong Performance Since 2024
-
Robot Orders Hold Steady in Q1 2026 as Demand Broadens Across Non-Automotive Industries
-
World Boss Media Named Media Sponsor at the Centurion One Capital Inaugural Miami Summit
-
Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree
-
Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease
-
First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026
-
Independent Cleveland Clinic Review Finds No Clinically Significant Cardiotoxicity with Moleculin's Annamycin in R/R AML Patients Dosed Beyond Conventional Anthracycline Limits
-
MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) to Report First Quarter 2026 Financial Results May 15
-
Star Bulk Announces Results of Its 2026 Annual Meeting of Shareholders
-
Independent Cleveland Clinic Review Finds No Clinically Significant Cardiotoxicity with Moleculin's Annamycin in R/R AML Patients Dosed Beyond Conventional Anthracycline Limits
-
Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress
-
Alpha Compute Closes $32.2 Million Revenue Contract with AI Lab Customer
-
Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias
